Florell Scott R, Meyer Laurence J, Boucher Kenneth M, Porter-Gill Patricia A, Hart Marybeth, Erickson Jennica, Cannon-Albright Lisa A, Pershing Lynn K, Harris Ronald M, Samlowski Wolfram E, Zone John J, Leachman Sancy A
The Melanoma Program, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112-5550, USA.
J Invest Dermatol. 2004 Sep;123(3):576-82. doi: 10.1111/j.0022-202X.2004.23312.x.
Phenotypic characteristics of members of a melanoma prone kindred with a V126D CDKN2A gene mutation were monitored over approximately 15 y. Thirty-eight previously studied subjects were recruited. Participants underwent a complete skin examination by the same dermatologist who examined them initially. The size and location of all nevi were recorded on a body map diagram. Total nevus number (TNN) and total nevus density (TND) were determined. CDKN2A sequencing verified 13 mutation carriers and 16 non-carriers. Nine participants were spouse controls without a history of melanoma and did not carry a CDKN2A mutation. Mutation carriers demonstrated a greater mean TNN and TND at initial and follow-up examinations compared with non-carriers and continued to develop nevi rather than show nevus regression seen in non-carriers and spouse controls. Non-carriers showed an intermediate nevus phenotype between mutation carriers and spouse controls. Four of the 13 mutation carriers and one non-carrier have developed invasive melanoma. Over a 15-y interval, TNN and TND were increased in mutation carriers compared with non-carriers and spouse controls. Continued accumulation of nevi in mutation carriers supports a nevogenic role for this CDKN2A mutation. An intermediate nevus phenotype in non-carrier family members suggests the presence of additional modifier genes.
对一个携带V126D CDKN2A基因突变的黑色素瘤易感家族成员的表型特征进行了约15年的监测。招募了38名之前已接受研究的受试者。参与者由最初检查他们的同一位皮肤科医生进行全面的皮肤检查。所有痣的大小和位置都记录在人体地图上。确定了痣总数(TNN)和总痣密度(TND)。CDKN2A基因测序验证了13名突变携带者和16名非携带者。9名参与者为配偶对照,无黑色素瘤病史且不携带CDKN2A突变。与非携带者相比,突变携带者在初次和随访检查时的平均TNN和TND更高,并且继续出现新痣,而非像非携带者和配偶对照那样出现痣消退。非携带者表现出介于突变携带者和配偶对照之间的中间痣表型。13名突变携带者中的4名和1名非携带者已发展为侵袭性黑色素瘤。在15年的时间间隔内,与非携带者和配偶对照相比,突变携带者的TNN和TND有所增加。突变携带者中痣的持续积累支持了这种CDKN2A突变的致痣作用。非携带者家族成员中的中间痣表型表明存在其他修饰基因。